Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, ph... by Ledermann, Jonathan A, Prof, Oza, Amit M, MD, Lorusso, Domenica, MD, Aghajanian, Carol, MD, Oaknin, Ana, MD, Dean, Andrew, MD, Colombo, Nicoletta, Prof, Weberpals, Johanne I, MD, Clamp, Andrew R, PhD, Scambia, Giovanni, MD, Leary, Alexandra, MD, Holloway, Robert W, MD, Gancedo, Margarita Amenedo, MD, Fong, Peter C, FRACP, Goh, Jeffrey C, FRACP, O'Malley, David M, MD, Armstrong, Deborah K, MD, Banerjee, Susana, PhD, García-Donas, Jesus, MD, Swisher, Elizabeth M, Prof, Cameron, Terri, MSc, Maloney, Lara, BA, Goble, Sandra, MS, Coleman, Robert L, MD

Get full text

Ibrutinib Versus Ofatumumab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Results From the Randomized Phase III RESONATE™ (PCYC-1112) Tri... by Brown, J. Jennifer R., MD, PhD, Byrd, John C., MD, O’Brien, Susan, MD, Barrientos, Jacqueline C., MD, Kay, Neil E., MD, Reddy, Nishitha M., MBBS, MD, Coutre, Steven, MD, Tam, Constantine S., MBBS, MD, Mulligan, Stephen, MBBS, PhD, FRACP, FRCPA, Jaeger, Ulrich, MD, Devereux, Stephen, PhD, FRCP, FRCPath, Barr, Paul M., MD, Furman, Richard, MD, Kipps, Thomas, MD, PhD, Cymbalista, Florence, MD, PhD, Fardis, Maria, PhD, MBA, McGreivy, Jesse, MD, Clow, Fong, DSc, James, Danelle F., MD, MAS, Hillmen, Peter, MD, PhD, FRCP, FRCPath

Get full text